The Louisiana-based company offers its Ellipse Spinal Cord Stimulator Platform for treating chronic pain. The platform includes the company's patented and FDA-cleared StimuLux technology, which uses ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...

The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, ...

Using advanced precision neuromodulation technology, Kautz and the MUSC team are able to apply the latest imaging techniques to identify specific dysfunctional neural circuits. They then use advanced ...

At the forefront of this shift is Nuropod, a U.S.-available, non-invasive, ear-worn vagus nerve stimulation wearable designed to help support reductions in symptoms associated with persistent fatigue, ...

The International Neuromodulation Society (INS) journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of ...

IRVINE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences (RSLS) ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the ...

IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company ...

Vivani Medical will spin off Cortigent, its neurostimulation business, as an independently publicly traded company as it looks to prioritise its portfolio of weight loss drug implants. While Vivani ...